Healthcare provider profile · identity verified

Amanda Born Bernath, M.D.

Family Practice · SHAWANO, WI · NPI 1083024277

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	518	146
Amlodipine Besylate	Amlodipine Besylate	376	120
Lisinopril	Lisinopril	362	114
Omeprazole	Omeprazole	358	100
Levothyroxine Sodium	Levothyroxine Sodium	276	64
Rosuvastatin Calcium	Rosuvastatin Calcium	259	77
Metoprolol Succinate	Metoprolol Succinate	240	79
Losartan Potassium	Losartan Potassium	194	64
Metformin Hcl Er	Metformin Hcl	166	46
Furosemide	Furosemide	163	51
Spironolactone	Spironolactone	153	47
Sertraline Hcl	Sertraline Hcl	134	32
Eliquis	Apixaban	129	31
Hydrochlorothiazide	Hydrochlorothiazide	124	48
Jardiance	Empagliflozin	122	39
Metoprolol Tartrate	Metoprolol Tartrate	122	36
Pantoprazole Sodium	Pantoprazole Sodium	120	40
Trazodone Hcl	Trazodone Hcl	115	32
Simvastatin	Simvastatin	114	36
Fluoxetine Hcl	Fluoxetine Hcl	102	25
Trulicity	Dulaglutide	97	14
Gabapentin	Gabapentin	94	34
Famotidine	Famotidine	91	25
Warfarin Sodium	Warfarin Sodium	86	12
Metformin Hcl	Metformin Hcl	81	27
Duloxetine Hcl	Duloxetine Hcl	80	22
Potassium Chloride	Potassium Chloride	80	22
Allopurinol	Allopurinol	78	21
Myrbetriq	Mirabegron	70	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	69	20
Fluticasone Propionate	Fluticasone Propionate	66	32
Citalopram Hbr	Citalopram Hydrobromide	63	18
Prednisone	Prednisone	62	36
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	59	18
Synthroid	Levothyroxine Sodium	58	11
Albuterol Sulfate Hfa	Albuterol Sulfate	56	27
Xarelto	Rivaroxaban	54	12
Montelukast Sodium	Montelukast Sodium	53	suppressed
Mirtazapine	Mirtazapine	52	suppressed
Alendronate Sodium	Alendronate Sodium	48	19
Clopidogrel	Clopidogrel Bisulfate	48	15
Bupropion Xl	Bupropion Hcl	47	18
Escitalopram Oxalate	Escitalopram Oxalate	46	14
Ezetimibe	Ezetimibe	46	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	45	12
Lovastatin	Lovastatin	43	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	42	11
Glipizide	Glipizide	41	13
Tizanidine Hcl	Tizanidine Hcl	41	15
Pregabalin	Pregabalin	40	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	40	11
Carvedilol	Carvedilol	39	12
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	38	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	37	suppressed
Nystatin	Nystatin	35	17
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	35	suppressed
Lorazepam	Lorazepam	34	12
Doxazosin Mesylate	Doxazosin Mesylate	33	11
Atenolol	Atenolol	31	suppressed
Mounjaro	Tirzepatide	30	suppressed
Paroxetine Hcl	Paroxetine Hcl	30	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	29	suppressed
Breo Ellipta	Fluticasone/Vilanterol	28	suppressed
Cephalexin	Cephalexin	27	22
Ozempic	Semaglutide	26	suppressed
Valacyclovir	Valacyclovir Hcl	26	suppressed
Chlorthalidone	Chlorthalidone	25	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	25	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Carbamazepine	Carbamazepine	23	suppressed
Lidocaine	Lidocaine	23	suppressed
Memantine Hcl	Memantine Hcl	23	suppressed
Tramadol Hcl	Tramadol Hcl	23	suppressed
Meloxicam	Meloxicam	22	suppressed
Amoxicillin	Amoxicillin	21	12
Buspirone Hcl	Buspirone Hcl	21	suppressed
Finasteride	Finasteride	21	suppressed
Topiramate	Topiramate	21	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	20	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Clonazepam	Clonazepam	19	suppressed
Donepezil Hcl	Donepezil Hcl	19	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	19	suppressed
Pravastatin Sodium	Pravastatin Sodium	19	suppressed
Alprazolam	Alprazolam	18	suppressed
Baclofen	Baclofen	18	suppressed
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Temazepam	Temazepam	17	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	16	suppressed
Cimetidine	Cimetidine	15	suppressed
Incruse Ellipta	Umeclidinium Bromide	15	suppressed
Linzess	Linaclotide	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	14
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	14	suppressed
Methylphenidate Er	Methylphenidate Hcl	14	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	14	suppressed
Ondansetron Odt	Ondansetron	14	11
Acyclovir	Acyclovir	13	suppressed
Celecoxib	Celecoxib	13	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	13	suppressed
Diclofenac Sodium	Diclofenac Sodium	13	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	13	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Estradiol	Estradiol	13	suppressed
Fenofibrate	Fenofibrate,micronized	13	suppressed
Olanzapine	Olanzapine	13	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	13	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	12	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Prazosin Hcl	Prazosin Hcl	12	suppressed
Spiriva Handihaler	Tiotropium Bromide	12	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Aripiprazole	Aripiprazole	11	suppressed
Bydureon Bcise	Exenatide Microspheres	11	suppressed
Digoxin	Digoxin	11	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Ibandronate Sodium	Ibandronate Sodium	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed
Valsartan	Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error